Substituted quinazolines for inhibiting kinase activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9550770
SERIAL NO

14466896

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Chemical entities that are kinase inhibitors, pharmaceutical compositions containing the same, and methods of use thereof are described. Specifically quinazoline derivatives of Formula Ia:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUPHARMA INC3 EAST THIRD AVENUE SAN MATEO CA 94401

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Qian, Xiangping Foster City, US 122 1198
Zhu, Yong-Liang Fremont, US 58 1009

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 24, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00